Lite Strategy Stock Today
| LITS Stock | 1.11 0.01 0.89% |
PerformanceWeakest
| Odds Of DistressRisky
|
Lite Strategy is selling for under 1.11 as of the 17th of February 2026; that is 0.89% down since the beginning of the trading day. The stock's lowest day price was 1.06. Lite Strategy has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Lite Strategy symbol was changed from MEIP on 11th of September 2025. The performance scores are derived for the period starting the 19th of November 2025 and ending today, the 17th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of December 2003 | Category Healthcare | Classification Health Care |
Lite Strategy is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 36.77 M outstanding shares of which 201 K shares are now shorted by private and institutional investors with about 0.35 trading days to cover. More on Lite Strategy
Moving together with Lite Stock
Moving against Lite Stock
Lite Stock Highlights
| Older Symbol | MEIP | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CFO, CEO | Justin CPA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsLite Strategy can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Lite Strategy's financial leverage. It provides some insight into what part of Lite Strategy's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lite Strategy (LITS) is traded on NASDAQ Exchange in USA and employs 4 people. Lite Strategy was previously known as MEI Pharma and was traded on NASDAQ Exchange under the symbol MEIP. Lite Strategy is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.2 M. Lite Strategy conducts business under Biotechnology sector and is part of Health Care industry. The entity has 36.77 M outstanding shares of which 201 K shares are now shorted by private and institutional investors with about 0.35 trading days to cover.
Lite Strategy generates negative cash flow from operations
Check Lite Strategy Probability Of Bankruptcy
Ownership AllocationLite Strategy maintains a total of 36.77 Million outstanding shares. Lite Strategy secures significant amount of outstanding shares owned by insiders and institutional investors . Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lite Ownership Details
Lite Strategy Historical Income Statement
Lite Stock Against Markets
Additional Tools for Lite Stock Analysis
When running Lite Strategy's price analysis, check to measure Lite Strategy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lite Strategy is operating at the current time. Most of Lite Strategy's value examination focuses on studying past and present price action to predict the probability of Lite Strategy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lite Strategy's price. Additionally, you may evaluate how the addition of Lite Strategy to your portfolios can decrease your overall portfolio volatility.